HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma.
Wirtz
Paul W
PW
Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. pwwirtz@lumc.nl
Willcox
Nick
N
Roep
Bart O
BO
Lang
Bethan
B
Wintzen
Axel R
AR
Newsom-Davis
John
J
Verschuuren
Jan J
JJ
D018288:Carcinoma, Small Cell / Q000150:complications* / Q000235:genetics / Q000378:metabolism; D005787:Gene Frequency; D015795:HLA-B8 Antigen / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D015624:Lambert-Eaton Myasthenic Syndrome / Q000150:complications* / Q000235:genetics / Q000378:metabolism; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity
D015795:HLA-B8 Antigen